Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1998-2-3
pubmed:abstractText
1. Total RNA isolated from embryonic chick paravertebral sympathetic ganglia was used in a reverse transcription-polymerase chain reaction (RT-PCR) assay with a pair of degenerate oligonucleotide primers deduced from conserved regions of mammalian glycine receptor alpha-subunits. Three classes of cDNA were identified which encode portions of the chicken homologues of the mammalian glycine receptor alpha 1, alpha 2 and alpha 3 subunits. 2. The presence of functional glycine receptors was investigated in the whole-cell configuration of the patch-clamp technique in neurons dissociated from the ganglia and kept in culture for 7-8 days. In cells voltage clamped to -70 mV, glycine consistently induced inward currents in a concentration-dependent manner and elicited half-maximal peak current amplitudes at 43 microM. 3. The steady-state current-voltage relation for glycine-induced currents was linear between +80 and -60 mV, but showed outward rectification at more hyperpolarized potentials. Reversal potentials of these currents shifted with changes in intracellular chloride concentrations and matched the calculated Nernst potentials for chloride. 4. beta-Alanine and taurine were significantly less potent than glycine in triggering inward currents, with half-maximal responses at 79 and 86 microM, respectively. At maximally active concentrations, beta-alanine-evoked currents were identical in amplitude to those induced by glycine. Taurine-evoked currents, in contrast, never reached the same amplitude as glycine-induced currents. 5. The classical glycine receptor antagonist strychnine reversibly reduced glycine-induced currents, with half-maximal inhibition occurring at 62 nM. Two more recently characterized glycine receptor antagonists, isonipecotic acid (half-maximal inhibition at 2 mM) and 7-trifluoromethyl-4-hydroxyquinoline-3-carboxylic acid (half-maximal inhibition at 67 microM), also blocked glycine-evoked currents in a reversible manner. The chloride channel blocker picrotoxin reduced glycine-evoked currents, with half-maximal effects at 348 microM. Inhibition by the glycine receptor channel blocker cyanotriphenylborate was half-maximal at 4 microM. 6. Apart from evoking inward currents, glycine occasionally triggered short (< 100 ms) spike-like currents which were abolished by hexamethonium and thus reflected synaptic release of endogenous acetylcholine. In addition, glycine caused Ca(2+)-dependent and tetrodotoxin-sensitive tritium overflow from neurons previously labelled with [3H]noradrenaline. This stimulatory action of glycine was reduced in the presence of strychnine and after treatment with the chloride uptake inhibitor furosemide (frusemide). 7. In 65% of neurons loaded with the Ca2+ indicator fura-2 acetoxymethyl ester, glycine increased the ratio of the fluorescence signal obtained with excitation wavelengths of 340 and 380 nm, respectively, which indicates a rise in intracellular Ca2+ concentration. 8. The results show that sympathetic neurons contain transcripts for different glycine receptor alpha-subunits and carry functional heteromeric glycine receptors which depolarize the majority of neurons to trigger transmitter release.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-1376243, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-1385113, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-1685556, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-1722365, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-1726341, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-1797352, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-2338557, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-2411922, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-2443667, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-2470588, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-2547472, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-2600631, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-279023, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-3838314, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-4200724, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-4372629, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-501628, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-686171, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-7476923, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-7496626, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-7507926, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-7580154, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-7891186, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-7981869, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8057250, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8090751, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8176438, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8274276, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8404844, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8558472, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8667011, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8815920, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8816717, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-886334, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8873087, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-8913351, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-9089789, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-9151723, http://linkedlifedata.com/resource/pubmed/commentcorrection/9401974-9169916
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
504 ( Pt 3)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
683-94
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9401974-Amino Acid Sequence, pubmed-meshheading:9401974-Animals, pubmed-meshheading:9401974-Calcium, pubmed-meshheading:9401974-Cells, Cultured, pubmed-meshheading:9401974-Chick Embryo, pubmed-meshheading:9401974-Electric Stimulation, pubmed-meshheading:9401974-Electrophysiology, pubmed-meshheading:9401974-Glycine Agents, pubmed-meshheading:9401974-Membrane Potentials, pubmed-meshheading:9401974-Molecular Sequence Data, pubmed-meshheading:9401974-Neurons, pubmed-meshheading:9401974-Neurotransmitter Agents, pubmed-meshheading:9401974-Norepinephrine, pubmed-meshheading:9401974-Patch-Clamp Techniques, pubmed-meshheading:9401974-Polymerase Chain Reaction, pubmed-meshheading:9401974-Receptors, Glycine, pubmed-meshheading:9401974-Strychnine, pubmed-meshheading:9401974-Sympathetic Nervous System
pubmed:year
1997
pubmed:articleTitle
Glycine receptors in cultured chick sympathetic neurons are excitatory and trigger neurotransmitter release.
pubmed:affiliation
Max-Planck-Institut für Hirnforschung, Abteilung Neurochemie, Frankfurt/Main, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't